The use of a registry database in clinical trial design: Assessing the influence of entry criteria on statistical power and number of eligible patients
Authors:
- Linda PeelenLPLinda Peelen
- Niels PeekNPNiels Peek
- Evert de JongeEJEvert de Jonge
- Gert Jan SchefferGSGert Jan Scheffer
- Nicolette F. de KeizerNKNicolette F. de Keizer
- 1 February 2007
- journal article
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 76 (2-3) , 176-183
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Influence of entry criteria on mortality risk and number of eligible patients in recent studies on severe sepsis*Critical Care Medicine, 2005
- Balancing the number and size of sites: an economic approach to the optimal design of cluster samplesControlled Clinical Trials, 2003
- Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failureCritical Care Medicine, 2003
- Decision support tools for clinical trial designArtificial Intelligence in Medicine, 2003
- Defining and Improving Data Quality in Medical Registries: A Literature Review, Case Study, and Generic FrameworkJournal of the American Medical Informatics Association, 2002
- Treating Patients with Severe SepsisNew England Journal of Medicine, 1999
- DOES SAMPLE DESIGN MATTER FOR POVERTY RATE COMPARISONS?Review of Income and Wealth, 1998
- Statistics notes: Sample size in cluster randomisationBMJ, 1998
- Statistics notes: Absence of evidence is not evidence of absenceBMJ, 1995
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992